Back
Nxera Pharma 10K Form
Sell
49
SOLTF
Nxera Pharma
Last Price:
8.05
Seasonality Move:
14.44%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SOLTF News And Ratings
See the #1 stock for the next 7 days that we like better than SOLTF
SOLTF Financial Statistics
Sales & Book Value
| Annual Sales: | $90.99M |
|---|---|
| Cash Flow: | $10.3M |
| Price / Cash Flow: | 70.97 |
| Annual Sales: | $4.77 |
| Price / Book: | 1.69 |
Profitability
| EPS (TTM): | -0.27280 |
|---|---|
| Net Income (TTM): | $-24.56M |
| Gross Margin: | $68.88M |
| Return on Equity: | -15.46% |
| Return on Assets: | -2.4% |
Nxera Pharma Earnings Forecast
Key Nxera Pharma Financial Ratios
- The Gross Profit Margin over the past 19 years for SOLTF is 75.70%.
- The Selling, General & Administrative Expenses for SOLTF have been equal to 78.06% of Gross Profit Margin.
- The Research & Development expenses have been 78.92% of Revenue.
- The Interest Expense is -34.69% of Operating Income.
- The Net Earning history of SOLTF is -56.34% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 7 years.
Nxera Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | SOLTF |
| Website: | sosei.com |
Debt
| Debt-to-Equity Ratio: | 0.96 |
|---|---|
| Current Ratio: | 4.11 |
| Quick Ratio: | 3.85 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SOLTF Technical Analysis vs Fundamental Analysis
Sell
49
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy or a Sell?
-
Nxera Pharma stock is rated a Sell
The current Nxera Pharma [SOLTF] share price is $8.05. The Score for SOLTF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.